FSFlorence Sheen

Florence Sheen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Florence Sheen has a total of 51 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Using interactive education materials to empower children to be future consumers of alternative proteins: A randomised active-controlled trial

    by Aimee E. Pink, Kum Seong Wan, Siti Amelia Juraimi, Mansi Bhatnagar, Jolene Chee, Hui Si Oh, Joseph Simons, Pey Sze Teo, Florence Sheen, Mary F-F Chong, et al.

  • Open Access

    How do Artificial Intelligence chatbots respond to questions from adolescent personas about their eating, body weight or appearance?

    by Florence Sheen, Bethany Mullarkey, Gemma L. Witcomb, Marie‐Christine Opitz, Ellen Maloney, Saffron M. Baldoza, Hannah J. White

    Background: Body image and eating behaviours are common areas of concern for early adolescents. Artificial Intelligence (AI) interactions are becoming commonplace, including with chatbots that provide human‐like communication. Adolescents may prefer using chatbots to anonymously ask sensitive questions, rather than approaching trusted adults or peers. It is unclear how chatbots answer such questions. We explored how chatbots would respond to eating, weight or appearance‐related queries from adolescents. Method: Ten fictitious adolescent personas and scripts were created to facilitate conversations with ChatGPT and Claude.AI. Personas asked questions about eating, body weight and/or appearance, presenting as ‘curious’, ‘worried’ or ‘having a potential eating disorder’. Conversation outputs were analysed using reflexive thematic analysis to explore the content of chatbot responses. Results: Five themes were identified: (1) Live a ‘healthy’ adolescent lifestyle; (2) Eat ‘healthily’; (3) Promoting regular physical activity; (4) Seek support; (5) Focus on you. Advice was often framed within societal ideals relating to eating, body weight and/or appearance. Chatbots signposted to trusted adults and healthcare professionals for support, but not to regulated resources (e.g., NHS). Conclusion: Framings around eating, weight and/or appearance may be problematic for adolescents with eating disorder symptomatology. A lack of prompting for further information or signposting to regulated support means vulnerable adolescents may receive unhelpful information or not reach adequate support. Understanding how AI could be supportive and/or unhelpful to adolescent users presenting with eating, body or appearance‐related concerns is important. Findings can inform policy regulating AI chatbots' communications with adolescents.


  • Snack foods for babies: What is driving the increasing use of processed baby snack foods in the UK?

    by Alexandra Rhodes, Clare Llewellyn, Ivonne P.M. Derks, Florence Sheen, Andrea D. Smith, Alison Fildes, Andrew Steptoe, Rana Conway


  • Open Access

    Cross‐Sectional Associations Between Exposure to Commercial Milk Formula Marketing, Beliefs About Its Use, and Socioeconomic Position Among Pregnant Women and Mothers in the UK

    by Martha Athanasiadou, Florence Sheen, Andrea D. Smith, Clare Llewellyn, Rana Conway

    International provisions are in place to restrict marketing practices that idealise the use of commercial milk formula (CMF) and discourage breastfeeding. In high‐income countries, women of lower socioeconomic position (SEP) are less likely to breastfeed. This study aimed to characterise the nature of exposure to CMF marketing in the UK, the extent to which women hold positive beliefs about CMF and examine the relationship between exposure to CMF marketing, holding positive beliefs about CMF and SEP. Data on these topics were collected for 1052 pregnant women and mothers of children under 18 months of age between February 2020 and February 2021. Participants were assigned a ‘CMF marketing score’ according to the number of locations where they recalled seeing advertisements, engaging with companies or receiving promotional activity. The extent to which women held positive beliefs about CMF (‘CMF positivity score’) was determined by level of agreement with 17 statements. Principal component analysis, analyses of covariance and regression analyses were applied. Every woman reported exposure to CMF marketing from multiple channels. CMF marketing score did not vary across SEP groups (p = 0.342). Women of lower and middle SEP held stronger CMF positive beliefs than women of higher SEP, including ‘Breastfeeding and formula feeding provide a baby with the same health benefits’ (p < 0.005). CMF marketing score was not associated with CMF positivity score. Marketing suggesting CMF provides benefits similar to, or greater than, breastfeeding should be restricted to help mitigate current inequalities in infant feeding practices.


  • Open Access

    “It's most likely gonna be the future”: A qualitative study exploring child and parent perceptions of alternative proteins

    by Nandini Anant, Arunika Pillay, Siti Amelia Juraimi, Florence Sheen, Anna Fogel, Mary F-F. Chong, Benjamin P.C. Smith, Aimee E. Pink


  • Open Access

    Parents’ Responses and Reactions to the National Childhood Measurement Programme in a Contemporary Sample of British Children: A Mixed‐Method Study

    by Florence Sheen, Alice Kininmonth, Zeynep Nas, Alison Fildes, Clare Llewellyn

    Background: Parents’ support for the National Childhood Measurement Programme (NCMP, England) is typically mixed, with qualitative data from small samples of self‐selecting parents highlighting different responses depending on whether their child is classified as a ‘healthy’ or alternative weight. Objective: Using data from the Gemini cohort study, we explored parents’ emotional and behavioural responses to feedback on their children’s weight status. Methods: We performed secondary data analysis on data collected when children were 12–13 years old (2019–2021). Their parents completed a questionnaire online, which included (optional) questions about the NCMP. Parents indicated the weight status assigned to their child by the NCMP and answered questions about the weight feedback, including an open‐ended question about their emotional responses. Results: There were 567 complete responses to the NCMP questions (55.8% of parents who completed the questionnaire). The majority of children were categorised as ‘healthy weight’ ( n = 440, 77.6%). Among parents whose children were categorised as an alternative weight status ( n = 101), 29.7%, 54.5% and 45.0% of those with children categorised as underweight, overweight or very overweight, respectively, reported that they took action following the NCMP feedback. Qualitative results highlighted emotional responses and inferences made about children’s well‐being based on the feedback received; parents usually reacted positively (happy, inferred their child was healthy) if their child was categorised as a healthy weight, and negatively (worried, inferred their child was not healthy) if their child was categorised as an alternative weight status. There was also some distrust of the feedback and the NCMP itself. Conclusion: The negative reactions of many parents to NCMP feedback, and the programme itself, highlight the need to involve parents and caregivers in the delivery of the NCMP and framing of feedback. Parent and caregiver input is vital to understand how best to communicate information about children’s weight to parents, signpost them to support and what support pathway should be implemented to increase parent uptake.


  • Open Access

    Evaluating the Onset, Severity, and Recovery of Changes to Smell and Taste Associated With COVID-19 Infection in a Singaporean Population (the COVOSMIA-19 Trial): Protocol for a Prospective Case-Control Study

    by Florence Sheen, Vicki Tan, Sumanto Haldar, Sharmila Sengupta, David Allen, Jyoti Somani, Hui Yee Chen, Paul Tambyah, Ciaran G Forde

    Background: Sudden loss of smell and/or taste has been suggested to be an early marker of COVID-19 infection, with most findings based on self-reporting of sensory changes at a single time point. Objective: To understand the onset, severity, and recovery of sensory changes associated with COVID-19 infection, this study will longitudinally track changes in chemosensory acuity among people with suspected COVID-19 infection using standardized test stimuli that are self-administered over 28 days. Methods: In a prospective, case-controlled observational study, volunteers will be recruited when they present for COVID-19 screening by respiratory tract polymerase chain reaction test (“swab test”). The volunteers will initially complete a series of questionnaires to record their recent changes in smell and taste ability, followed by a brief standardized smell and taste test. Participants will receive a home-use smell and taste test kit to prospectively complete daily self-assessments of their smell and taste acuity at their place of residence for up to 4 weeks, with all data submitted for collection through web-based software. Results: This study has been approved by the Domain Specific Review Board of the National Healthcare Group, Singapore, and is funded by the Biomedical Research Council Singapore COVID-19 Research Fund. Recruitment began on July 23, 2020, and will continue through to March 31, 2021. As of October 2, 2020, 69 participants had been recruited. Conclusions: To our knowledge, this study will be the first to collect longitudinal data on changes to smell and taste sensitivity related to clinically diagnosed COVID-19 infection, confirmed by PCR swab test, in a population-based cohort. The findings will provide temporal insights on the onset, severity, and recovery of sensory changes with COVID-19 infection, the consistency of symptoms, and the frequency of full smell recovery among patients with COVID-19. This self-administered and cost-effective approach has many advantages over self-report questionnaire–based methods and provides a more objective measure of smell and taste changes associated with COVID-19 infection; this will encourage otherwise asymptomatic individuals who are potential spreaders of the virus to self-isolate and seek formal medical diagnosis if they experience a sudden change in sensory acuity. This broadened case finding can potentially help control the COVID-19 pandemic and reduce the emergence of clusters of infections. Clinical Trial: ClinicalTrials.gov NCT04492904; https://clinicaltrials.gov/ct2/show/NCT04492904.


  • Open Access

    Evaluating the Onset, Severity, and Recovery of Changes to Smell and Taste Associated With COVID-19 Infection in a Singaporean Population (the COVOSMIA-19 Trial): Protocol for a Prospective Case-Control Study (Preprint)

    by Florence Sheen, Vicki Tan, Sumanto Haldar, Sharmila Sengupta, David Allen, Jyoti Somani, Hui Yee Chen, Paul Tambyah, Ciaran G Forde

    BACKGROUND Sudden loss of smell and/or taste has been suggested to be an early marker of COVID-19 infection, with most findings based on self-reporting of sensory changes at a single time point. OBJECTIVE To understand the onset, severity, and recovery of sensory changes associated with COVID-19 infection, this study will longitudinally track changes in chemosensory acuity among people with suspected COVID-19 infection using standardized test stimuli that are self-administered over 28 days. METHODS In a prospective, case-controlled observational study, volunteers will be recruited when they present for COVID-19 screening by respiratory tract polymerase chain reaction test (“swab test”). The volunteers will initially complete a series of questionnaires to record their recent changes in smell and taste ability, followed by a brief standardized smell and taste test. Participants will receive a home-use smell and taste test kit to prospectively complete daily self-assessments of their smell and taste acuity at their place of residence for up to 4 weeks, with all data submitted for collection through web-based software. RESULTS This study has been approved by the Domain Specific Review Board of the National Healthcare Group, Singapore, and is funded by the Biomedical Research Council Singapore COVID-19 Research Fund. Recruitment began on July 23, 2020, and will continue through to March 31, 2021. As of October 2, 2020, 69 participants had been recruited. CONCLUSIONS To our knowledge, this study will be the first to collect longitudinal data on changes to smell and taste sensitivity related to clinically diagnosed COVID-19 infection, confirmed by PCR swab test, in a population-based cohort. The findings will provide temporal insights on the onset, severity, and recovery of sensory changes with COVID-19 infection, the consistency of symptoms, and the frequency of full smell recovery among patients with COVID-19. This self-administered and cost-effective approach has many advantages over self-report questionnaire–based methods and provides a more objective measure of smell and taste changes associated with COVID-19 infection; this will encourage otherwise asymptomatic individuals who are potential spreaders of the virus to self-isolate and seek formal medical diagnosis if they experience a sudden change in sensory acuity. This broadened case finding can potentially help control the COVID-19 pandemic and reduce the emergence of clusters of infections. CLINICALTRIAL ClinicalTrials.gov NCT04492904; https://clinicaltrials.gov/ct2/show/NCT04492904. INTERNATIONAL REGISTERED REPORT DERR1-10.2196/24797

  • Food waste concerns, eating behaviour and body weight

    by Florence Sheen, Charlotte A. Hardman, Eric Robinson